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NEWS AND COMMENTARY
Polygenic risk scores for schizophrenia and depression linked to OCD
Polygenic prediction of obsessive compulsive symptoms
NR Zilhão1,2, A Abdellaoui1, DJA Smit3, DC Cath2,4, JJ Hottenga1 and DI Boomsma1
Molecular Psychiatry (2018) 23, 168–169; doi:10.1038/mp.2017.248;
published online 5 December 2017
Obsessive compulsive disorder (OCD) is a common neuropsychia-
tric disorder, causing considerable social impairment and disease
burden worldwide.1 OCD is characterized by the presence of a
heterogeneous array of 'clinically significant' obsessions and
compulsions, in a permanent uncontrollable cycle. It is widely
recognized, similarly to what is observed for other psychiatric
disorders, that individual differences in the susceptibility to OCD
are at least partly genetic.1
Twin and family studies estimate the heritability of OCD to be
between 0.27 and 0.50. Molecular genetic studies in epidemiolo-
gical samples offer evidence for the highly polygenic nature of
OCD, i.e., OCD is influenced by large numbers of (common)
genetic variants with small-effects.1 This polygenicity is within the
expectations, considering the findings on the genetic architecture
of other psychiatric traits.
Polygenic risk scores (PRS) offer an opportunity to test if results
from large meta-analyses for psychiatric disorders can predict
OCD. PRS are a measure of an individual’s genetic risk to develop a
certain disorder, calculated by summing all genotype scores for a
person after weighting them by their estimated effect size for a
trait as obtained from a genetic association analysis. These scores
can be used to test the predictive value of a PRS towards the
disorder in independent samples, or towards another disorder of
interest. This approach allows one to simultaneously (1) tackle the
inherent culprit of polygenicity surrounding complex traits—that
true genetic variance is captured by the full set of measured SNPs
not only significant signals, and (2) assess to which extent the
individual genetic risk to a trait has predictive value for another
trait—serving as measure of genetic correlation between dis-
orders, even in the absence of phenotype measurements for
multiple disorders.2
Recently, large GWASs for psychiatric traits have been
completed and we constructed polygenic scores based on the
summary statistics from a series of disorders that are epidemio-
logically related to OCD, namely: Attention Deficit Hyperactivity
Disorder (ADHD), Bipolar Disorder (BD), Schizophrenia (SCZ), major
depressive disorder (MDD), Autism, and Migraine. In addition we
had at our disposal summary statistics from a meta-analysis
performed on clinically-derived OCD samples from the Interna-
tional OCD Foundation Genetic Collaborative (IOCDFGC) and OCD
Collaborative Genetics Association Study (OCGAS).3,4 We investi-
gated the power of each of these scores to effectively predict
obsessive compulsive symptoms (OCS) in a population-based
sample, considering different values for genetic correlations
between the score and OCS, following the method proposed by
Dubridge.2
Table 1 summarizes the results. The polygenic scores for OCD,
SCZ (P= 1.4 × 10− 6), MDD (P= 5.6 × 10− 5) and BP-SCZ combined
(P= 8.1 × 10− 7) were significant after correcting for multiple
testing (α= 0.006). This last result is probably driven by the
Table 1. Results of the GEE association analyses between OCS and different polygenic scores (N= 6506)
Polygenic score P- value R2 (%) N-GWAS h2 LDSC Power (rg = 0.2) Power (rg = 0.4) Power (rg = 0.6) Power (rg = 0.8)
OCD3,4 3.0 ×10− 4 0.57 9761 0.14 0.18 0.54 0.87 0.99
ADHD5 0.85 0.39 51 306 0.23 0.84 0.84 1 1
Bipolar Disorder (BD)6 0.015 0.48 63 766 0.43 0.29 0.29 0.98 1
Schizophrenia7 1.4 ×10− 6 0.71 79 845 0.45 0.97 0.97 1 1
BD & Schizophrenia6 8.1 ×10− 7 0.79 39 202 0.37 0.48 0.48 0.99 1
BD vs Schizophrenia6 0.025 0.44 16 381 0.33 0.11 0.11 0.78 1
MDD (PGC and 23andMe)8 5.6 ×10− 5 0.57 370 973 0.07 0.78 0.98 1 1
Autism9 0.47 0.38 10 263 0.46 0.12 0.12 0.81 1
Migraine10 0.16 0.41 196 685 0.04 0.03 0.03 0.31 0.99
Abbreviations: ADHD, attention deficit hyperactivity disorder; GEE, generalized estimation equations; MDD, major depressive disorder; OCD, obsessive
compulsive disorder; OCS, obsessive compulsive symptoms. The third column also indicates the proportion (in percentage of variance explained in OCS by
each polygenic risk score (R2). N-GWAS gives sample size and h2 the heritability estimates (h2 LDSC) of the GWAS summary statistics from LD score regression.
The last 4 columns give the power to detect an association between OCS and the polygenic scores given a genetic correlation (rg) of 0.2, 0.4, 0.6 and 0.8. Bold
font indicates significant P-values after multiple testing correction (α= 0.05/9= 0.006); gray color font indicates nominally significant P-values (α= 0.05). The
reference for the provenance of each summary statistics is given alongside the respective score.
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genetic component that Schizophrenia shares with BD. Overall,
the polygenic scores explained between 0.38–0.79% of the total
variance of OCS—in line with what is observed for most PRS
analysis. The score ‘BD vs Schizophrenia’—which includes the
genetic component that differentiates between BD and Schizo-
phrenia, did not significantly predict OCS, which indicates that
genetic variation unique to SCZ or BIP is not related to OCS. MDD
scores also showed a strong genetic association with OCS. Among
the most co-occurring disorders with OCD are major depression
(31%) and BD (7%), while for schizophrenia rates for co-occurrence
are rare. These results indicate that the reason for comorbidity
partly is genetic, with a shared genetic liability to OCS.
These results show that population-based OCS can be predicted
with the help of clinically based GWAS, which in turn reveals that
psychiatric genetic risk factors can lead to the presence of sub-
clinical OC symptoms. The risk scores also indicate that OCS are
clinically relevant markers of other psychiatric disorders related to
OCD. In other words, sub-clinical OCS shares genetic variance that
underlies OCD, Schizophrenia and MDD.
The relevance of PRS lies within their predictive value. PRS have
a better predictive value than the individual GWASs’ top hits. Their
application may in many cases be clinically useful when applied to
population-based samples (as herein shown), and predict the
development of psychiatric traits such as OCD. Our results
regarding the predictive value of MDD and Schizophrenia for
OCS should be looked into in further studies.
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